DAX Modestly Higher As Earnings Drive Mixed Trading
Germany’s DAX rose modestly in Thursday morning trading, reaching 26,210.50 before easing to 26,169.49 (+0.12%). Deutsche Telekom gained about 6% on Q2 operating profit of €6.863bn and a larger 2026 buyback. Merck rose 1.5% after upgrading full-year guidance. Other moves included Henkel (+4.3%) and Siemens (-6%).
How this was made
The 30-second read
Why it matters
The actionable part is the set of company-specific catalysts: Telekom buyback expansion, Merck guidance corridor upgrade, Commerzbank profitability improvement, Nordex order win, and notable downside reactions in Siemens and Scout24. Macro prints (construction PMI, factory orders, car registrations, Euro zone retail sales) add a second layer of risk appetite and cyclicality.
Market read
Traders can use the disclosed catalysts to position around earnings-driven repricing in specific DAX constituents, while macro data informs cyclicality and rates-sensitive sentiment.
What to watch
For Siemens and Scout24, the excerpt does not state what disappointed investors; without that, traders may misread the directionality and size of subsequent revisions.
Background
This is a DAX morning market wrap centered on company earnings updates and fresh German and Euro zone economic data, plus mention of Middle East developments.
Ticker impact
Deutsche Telekom shares rose about 6% after Q2 operating profit and revenue beat prior year and it expanded its 2026 buyback by up to €3B.
Mild to moderate positive follow-through possible if traders extrapolate buyback and earnings momentum.
The article ties the move directly to Q2 results and a larger repurchase authorization, both typically supportive for valuation and sentiment.
Merck rose about 1.5% after upgrading full-year guidance target corridors, alongside Q2 net income of €494M and net sales growth.
Moderate positive bias for the next few sessions as traders adjust FY estimates to the new corridor.
A guidance upgrade is a concrete catalyst; the article also includes Q2 income and sales growth to support the narrative.
Fresenius Medical Care moved up a little over 2% as part of the DAX earnings-driven trading, with no specific figures included here.
Low conviction; follow-through depends on details not present in the text.
The article does not provide the company-specific earnings/guidance facts needed to underwrite a trade.
Market effects
Earnings-led tape across telecom, industrials, chemicals, and financials, with construction and factory-order data adding macro sensitivity.
Germany-focused risk sentiment, with DAX directionality tied to company prints plus German construction and factory-order momentum.
Limited direct global spillover, but guidance upgrades and order wins can influence European industrial and credit sentiment.
Counterpoint
The index is moving on headline earnings reactions, but the excerpt lacks the specific guidance or margin drivers behind several large moves, so follow-through may be overstated.
Key entities
- indexDAX
German benchmark index moving slightly higher as earnings and regional economic data are digested.
- companyDeutsche Telekom
Q2 operating profit and revenue increased and it expanded its 2026 share buyback program by up to €3B.
- companyMerck
Upgraded full-year guidance target corridors after reporting Q2 net income and sales growth.
- companyCommerzbank
Reported Q2 net result attributable to shareholders of €898M and operating result up about 17%.
- companyNordex
Secured an order to supply and install wind turbines totaling about 525 MW.
